Pazopanib Completed Phase 4 Trials for Metastatic Renal Cell Carcinoma ( mRCC) Other
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Other | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02555748 | Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma |